The SNRPN gene plays a crucial role in the genetic testing for Prader-Willi Syndrome (PWS), a complex genetic disorder characterized by a variety of symptoms including developmental delays, poor muscle tone, feeding difficulties in infancy, and overeating in later childhood. This condition is caused by the loss of function of specific genes on chromosome 15, with the SNRPN gene being one of the key genes involved.
At DNA Labs UAE, individuals can undergo a genetic test specifically targeting the SNRPN gene to determine if they have Prader-Willi Syndrome. This test is particularly important for early diagnosis and intervention, which can significantly improve the quality of life for those affected by PWS. The process involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for abnormalities associated with the SNRPN gene.
The cost of the SNRPN gene Prader-Willi Syndrome genetic test at DNA Labs UAE is 4400 AED. This price reflects the comprehensive nature of the test, including the sophisticated technology and expertise required to accurately identify mutations in the SNRPN gene. Early diagnosis through genetic testing can be a critical step in managing the symptoms of Prader-Willi Syndrome and providing the necessary support and treatments for those affected.
The ALS2 gene primary lateral sclerosis juvenile genetic test is a specialized diagnostic examination aimed at detecting mutations in the ALS2 gene, which are associated with the development of juvenile primary lateral sclerosis (JPLS). JPLS is a rare neurological disorder characterized by progressive weakness and stiffness of muscles in the arms, legs, and face. This condition typically manifests in childhood or adolescence and progresses over time, leading to significant motor disabilities.
The test is conducted at DNA Labs UAE, a leading facility in genetic testing and analysis. The procedure involves collecting a DNA sample from the patient, usually through a blood draw or cheek swab. The sample is then analyzed using advanced genetic sequencing technologies to identify any mutations in the ALS2 gene that are indicative of JPLS.
The cost of the ALS2 gene primary lateral sclerosis juvenile genetic test at DNA Labs UAE is 4400 AED. This price reflects the comprehensive nature of the test, including the sophisticated technology and expertise required to accurately identify the genetic markers associated with the condition. Patients considering this test are often advised to consult with a genetic counselor or medical specialist to understand the implications of the results and to explore potential treatment options and management strategies for JPLS.
The POLG Gene Progressive External Ophthalmoplegia with Mitochondrial Deletions Type 1 Autosomal Dominant Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the POLG gene. These mutations are associated with a specific form of progressive external ophthalmoplegia (PEO), a condition characterized by weakness of the eye muscles and other systemic symptoms due to mitochondrial abnormalities. The test is crucial for confirming the diagnosis, understanding the disease's progression, and guiding treatment strategies.
Performed at DNA Labs UAE, the test involves analyzing the patient's DNA to detect deletions or mutations in the POLG gene, which plays a pivotal role in mitochondrial DNA replication and repair. Mutations in this gene can lead to mitochondrial dysfunction, manifesting in various symptoms, including muscle weakness, exercise intolerance, and neurological deficits, alongside the characteristic eye muscle weakness.
The cost of the test is 4400 AED, reflecting the comprehensive analysis and the specialized technology required to accurately identify the genetic alterations associated with this condition. Given the autosomal dominant inheritance pattern of this form of PEO, the test is also valuable for family planning and genetic counseling, providing crucial information for affected individuals and their families.
The SLC25A4 gene, associated with Progressive External Ophthalmoplegia with Mitochondrial Deletions Type 2 (PEO2), plays a crucial role in mitochondrial function and energy production. PEO2 is a genetic disorder characterized by weakness in the muscles that control eye and eyelid movement, leading to drooping eyelids (ptosis) and difficulty moving the eyes (ophthalmoplegia). It may also involve muscle weakness in other parts of the body. This condition is autosomal dominant, meaning a single copy of the altered gene in each cell is sufficient to cause the disorder.
To diagnose this condition, a specific genetic test is available at DNA Labs UAE, which analyzes the SLC25A4 gene for mutations that are known to cause the disorder. The test is priced at 4400 AED. It is a critical step for individuals showing symptoms of PEO2 or those with a family history of the condition, as it can confirm the diagnosis and inform treatment strategies. Furthermore, the test can provide essential information for family planning decisions for those carrying the mutation.
The RNASEH1 gene plays a crucial role in maintaining the integrity of mitochondrial DNA, which is essential for normal cellular energy production. Mutations in the RNASEH1 gene can lead to Progressive External Ophthalmoplegia with Mitochondrial Deletions, Type 2, an autosomal recessive disorder. This condition is characterized by weakness in the muscles that control eye and eyelid movement, leading to drooping eyelids (ptosis) and difficulty moving the eyes, which can result in double vision. Additionally, affected individuals may experience muscle weakness in other parts of the body.
To diagnose this condition, a genetic test targeting the RNASEH1 gene can be performed. DNA Labs UAE offers this specialized genetic test, which is designed to identify mutations in the RNASEH1 gene that are associated with the development of Progressive External Ophthalmoplegia with Mitochondrial Deletions, Type 2. The test is crucial for confirming the diagnosis, understanding the disease's progression, and guiding treatment options.
The cost of the RNASEH1 gene genetic test at DNA Labs UAE is 4400 AED. The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of specific mutations in the RNASEH1 gene. This test is an important tool for individuals experiencing symptoms of Progressive External Ophthalmoplegia with Mitochondrial Deletions, Type 2, or for those with a family history of the condition, as it can provide a definitive diagnosis and facilitate appropriate management and genetic counseling.
The TWNK Gene Progressive External Ophthalmoplegia with Mitochondrial Deletions Type 3 Autosomal Dominant Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE. This test is designed to identify mutations in the TWNK gene, which have been associated with Progressive External Ophthalmoplegia (PEO) Type 3, a condition characterized by weakness of the eye muscles and, in some cases, other systemic symptoms due to mitochondrial deletions. PEO is an autosomal dominant disorder, meaning that a mutation in just one of the two copies of the gene can lead to the condition.
PEO can lead to symptoms such as drooping eyelids, difficulty moving the eyes, and in more severe cases, can affect other muscles in the body. The presence of mitochondrial deletions adds complexity to the condition, potentially leading to a broader spectrum of symptoms, including but not limited to muscle weakness, heart issues, and neurological deficits.
The genetic test offered by DNA Labs UAE for this condition costs 4400 AED. It involves analyzing the patient's DNA to look for specific mutations in the TWNK gene that are known to cause the disorder. This test is crucial for accurate diagnosis and can also provide valuable information for family planning and understanding the risk of passing the condition to offspring. Early diagnosis through genetic testing can also assist in the management of symptoms and in improving the quality of life for those affected by PEO.
The POLG2 gene test for Progressive External Ophthalmoplegia with Mitochondrial Deletions Type 4 (autosomal dominant) is a specialized genetic test available at DNA Labs UAE. This test is designed to identify mutations in the POLG2 gene, which are associated with the development of Progressive External Ophthalmoplegia (PEO) type 4. PEO is a disorder characterized by weakness of the muscles around the eyes and eyelids (leading to drooping eyelids and difficulty moving the eyes), and can also affect other muscles in the body. The autosomal dominant inheritance pattern means that a mutation in just one of the two copies of the gene can cause the condition.
The test is crucial for individuals who have a family history of PEO or show symptoms suggestive of the disorder, as it helps in confirming the diagnosis, understanding the risk of passing the mutation to offspring, and guiding management and treatment options. The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed for the presence of mutations in the POLG2 gene.
The cost of the POLG2 gene test at DNA Labs UAE is 4400 AED. This price may cover the cost of the sample collection, genetic analysis, and the provision of a comprehensive report that explains the results. It is advisable for individuals considering this test to consult with a genetic counselor or a healthcare provider to understand the implications of the test results for themselves and their family members.
The "RRM2B Gene Progressive External Ophthalmoplegia with Mitochondrial Deletions Type 5 Autosomal Dominant Genetic Test" is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the RRM2B gene. These mutations are associated with a form of progressive external ophthalmoplegia (PEO), a condition characterized by weakness of the eye muscles and, in some cases, other muscles in the body. This particular type of PEO, known as Type 5, is autosomal dominant, meaning that only one copy of the mutated gene inherited from a parent is sufficient to cause the condition. This test plays a crucial role in the accurate diagnosis and understanding of the genetic basis of the disease, which can significantly impact treatment decisions and family planning. The cost of the test is 4400 AED, reflecting the specialized nature of the genetic analysis and the expertise required to interpret the results. Conducted at DNA Labs UAE, this test is a vital resource for individuals and families affected by this rare genetic condition, offering insights into the genetic underpinnings and aiding in the management of the disease.
The PRICKLE1 Gene Progressive Myoclonus Epilepsy Type 1A Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the PRICKLE1 gene, which are associated with Progressive Myoclonus Epilepsy Type 1A (PME 1A). PME 1A is a rare genetic disorder characterized by myoclonic seizures, epileptic episodes, and potentially progressive neurological decline. The test is crucial for individuals displaying symptoms suggestive of PME 1A or for those with a family history of the condition, as it aids in confirming the diagnosis, understanding the disease's progression, and tailoring appropriate treatment plans.
The testing process involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any genetic abnormalities in the PRICKLE1 gene. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in this specific gene. Early and precise diagnosis through the PRICKLE1 Gene Progressive Myoclonus Epilepsy Type 1A Genetic Test enables healthcare providers to offer better management strategies for affected individuals, potentially improving their quality of life.
The KCTD7 gene progressive myoclonus epilepsy type 3 genetic test is a specialized diagnostic tool designed to detect mutations in the KCTD7 gene, which are associated with progressive myoclonus epilepsy type 3 (PME3), a rare and severe neurological disorder. This condition is characterized by a combination of myoclonic seizures, epileptic episodes, and, in some cases, cognitive decline. Early and accurate diagnosis through genetic testing is crucial for the management and treatment of PME3, as it allows for tailored treatment plans and helps families understand the genetic implications of the condition.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, usually through a blood draw or cheek swab, and analyzing the genetic material for specific mutations in the KCTD7 gene. DNA Labs UAE employs state-of-the-art technology and expertise to ensure high accuracy and reliability of the test results.
The cost of the KCTD7 gene progressive myoclonus epilepsy type 3 genetic test at DNA Labs UAE is 4400 AED. While the price may seem significant, the value of obtaining a precise diagnosis cannot be understated, as it plays a critical role in the effective management of the condition and in providing genetic counseling for affected families.
